Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells

Clinical and Experimental Metastasis

Volumn 19, Issue 6, 2002, Pages 541-550

  Zimmer, Regis ^a   Thomas, Peter ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Expression profiling; Interferon beta; Liver; Metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GENE PRODUCT; MUCIN; RECOMBINANT BETA INTERFERON;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CYCLE; CELL GROWTH; CELL SURVIVAL; CLUSTER ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

ANIMALS; APOPTOSIS; CARCINOEMBRYONIC ANTIGEN; CELL CYCLE; CELL SURVIVAL; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-BETA; LIVER NEOPLASMS; MICE; MICE, NUDE; MUCINS; NEOPLASM PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036398305     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020325327461     Document Type: Article

References (38)

1. Jessup JM, Thomas P. Cell adhesion and communication mediated by the CEA family: Basic and clinical perspectives. In Stanners CP (ed): CEA and Metastasis: a Facilitator of Site-Specific Metastasis. Amsterdam: Harwood Academic Publishers 1998; 195-222.
2. Schwartz B, Bresalier RS, Kim YS. The role of mucin in colon cancer metastasis. Int J Cancer 1992; 52: 60-5.
3. Lester BR, McCarthy JB. Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis. Cancer Metast Rev 1992; 11: 31-44.
4. Toth CA, Thomas P. The effect of interferon treatment on fourteen human colorectal cancer cell lines: Growth and carcinoembryonic antigen secretion in vitro. J Interferon Res 1990; 10: 579-88.
5. Toth CA. Effect of interferon treatment on the formation of hepatic metastasis by colorectal carcinomas in the nude mouse. Proc Am Assoc Cancer Res 1990; 31: 260.
6. Kondo H, Tanaka N, Naomoto Y et al. Anti-tumor effects of recombinant interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice. Japn J Cancer Res 1987; 78: 1258-63.
7. Wagner HE, Thomas P. Wolf BC et al. Characterization of the tumorigenic and metastatic potential of a poorly differentiated human colon cancer cell line. Invasion Metastasis 1990; 10: 253-66.
8. Kozlowski JM, Fidler IJ, Campbell D et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984; 44: 3522-9.
9. Toth CA, Thomas P. Type-I interferon resistance in a colorectal cancer cell line is associated with a more aggressive phenotype in vivo. Br J Cancer 1992; 65: 365-8.
10. Toth CA, Kowal A, Thomas P. Interferon induced modulation of cellular growth and antigen-expression by human colon tumor cells. Biochem Soc Trans 1988; 16: 1049-50.
11. Wagner HE, Toth CA, Steele GD et al. Invasive and metastatic potential of human colorectal cancer cell lines: Relationship to cellular differentiation and carcinoembryonic antigen production. Clin Exp Metastasis 1990; 10: 25-31.
12. Tibbetts LM, Doremus CM, Tzanakakis GN et al. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer 1993; 71: 315-21.
13. Xie K, Bielenberg D, Huang S et al. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by trasfection with the murine IFN-beta gene: Possible role of nitric oxide. Clin Cancer Res 1997; 3: 2283-94.
14. Licinio J, Prolo P, McCann SM et al. Brain iNOS: current understanding and clinical implications. Mol Med Today 1999; 5: 225-32.
15. Brune B, Lapetina EG. Protein thiol modification of glyceraldehyde-3-phostate dehydrogenase as a target for nitric oxide signalling. Genet Eng (NY) 1995; 17: 149-64.
16. Gao JJ, Filla MB, Lorsbach RB et al. Prolonged exposure of mouse macrophages to IFN-beta suppresses transcription of the inducible nitric oxide synthase gene: Altered availability of transcription factor STA lalpha. Eur J Immunol 2000; 30: 1551-61.
17. Sekine N, Ishikawa T, Okazaki T et al. Synergistic activation of NF-kappaB and inducible form of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells. J Cell Physiol 2000; 184: 46-57.
18. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 2001; 11: 66-75.
19. Di Cesare PE, Carlson CS, Attur M et al. Up-regulation of inducible nitric oxide synthase by the Swarm rat and human chondrosarcoma. J Orthop Res 1998; 16: 667-74.
20. Bruns CJ, Shinohara H, Harbison MT et al. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. Cancer Res 2000; 60: 2-7.
21. Shi Q, Huang S, Jiang W et al. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res 1999; 59: 2072-75.
22. Epner DE, Partin AW, Schalken JA et al. Association of glyceraldehydes-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 1993; 53: 1995-7.
23. Kim JW, Kim TE, Kim YW et al. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines. Antis Nucleic Acids Drug Dev 1999; 9: 507-13.
24. Tajima H, Tsuchiya K, Yamada M et al. Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. Neuroreport 1999; 10: 2029-33.
25. Tatton WG, Chalmers-Redman RM, Elstner M et al. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration apoptosis signaling. J Neural Transm Suppl 2000; 60: 77-100.
26. Fidler IJ. Angiogenesis and cancer metastasis. Cancer J Sci Am 2000; S: 134-41.
27. Dong Z, Greene G, Pettaway C et al. Suppression of angiogenesis and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 1999; 59: 872-9.
28. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metast Rev 1998; 17: 55-75.
29. Edmiston KH, Shoji Y, Mizoi T et al. Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells. Cancer Res 1998; 58: 1524-31.
30. Jessup JM, Battle P, Waller H et al. Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res 1999; 59: 1825-9.
31. Shi Q, Xiong Q, Wang B et al. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res 2001; 60: 2579-83.
32. Hotti A, Jarvinen K, Siivola P et al. Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases. Oncogene 2000; 19: 2354-62.
33. Gatei M, Scott SP, Filippovitch I, et al. Role for ATM in DNA damage induced phosphorylation of BRCA1. Cancer Res 2000; 60: 3299-304.
34. Hakam A, Yeatman TJ, Lu L et al. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol 1999; 30: 1128-33.
35. Akashi T, Ito E, Eishi Y et al. Reduced expression of Iaminin alpha 3 and alpha 5 chains in non-small cell lung cancers. Jpn J Cancer Res 2001; 92: 293-301.
36. Pfizenmaier K, Bartsch H, Scheurich P, et al. Differential gamma-interferon response of human colon carcinoma cells: Inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res 1985; 45: 3503-9.
37. Sollid L, Brandtzaeg P, Markussen G. Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 1987; 138: 4303-6.
38. Wadler S, Goldman M, Lyver A et al. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma. Cancer Res 1990; 50: 2056-9